康诺亚-B 港股通 空最新增减持 (2026-07-13) 官网 ( 02162.hk) | -42.95 | 8.09 | 0% | 上市时间2021-07-08股价83.60港币涨跌幅-3.91%成交金额1.76亿港币换手率0.70%市值249.74亿港币H股市值249.74亿港币总股本2.99亿H股本2.99亿每手股数500上市至今年化投资收益率4.35%港股通持仓占H股比例42.19% (102.90亿港币2026-07-17) 累计做空占H股比例6.49% (16.30亿港币2026-07-10) | |||
| 所属三级行业生物技术 (恒生) | 市盈率 | 122.42 | 市净率 | 4.47 | 股息率 | 0.37% | 恒生:医疗保健业药品及生物科技生物技术 |
| 所属指数指数纳入纳出 | |||||||
| 备注 (3): | 双击编辑备注 |
康诺亚-B(02162) - 历史董事名单
| # | 姓名 | 职衔 | 职位 | 委任日期 | 辞任日期 |
|---|---|---|---|---|---|
| 1 | 柯楊 | Independent Non Executive Director | 2021-07-08 | -- | |
| 2 | 羅卓堅 | Independent Non Executive Director - A/F | 2021-07-08 | -- | |
| 3 | 王小凡 | Independent Non Executive Director | 2021-07-08 | -- | |
| 4 | 劉林青 | Independent Non Executive Director | 2021-07-08 | 2023-06-27 | |
| 5 | 劉逸倫 | Non Executive Director | 2021-03-03 | -- | |
| 6 | WANG Chang Yu | Executive Director | 2021-03-03 | -- | |
| 7 | 王閩川 | Non Executive Director | 2021-03-03 | -- | |
| 8 | 呂東 | Non Executive Director | 2021-03-03 | 2022-03-29 | |
| 9 | 陳奇 | Non Executive Director | 2018-06-21 | -- | |
| 10 | 徐剛 | Executive Director | 2018-06-21 | -- | |
| 11 | BO Chen | Executive Director | 2018-04-23 | -- |